Skip to main content

Peer Review reports

From: Imatinib treatment of poor prognosis mesenchymal-type primary colon cancer: a proof-of-concept study in the preoperative window period (ImPACCT)

Original Submission
29 Nov 2016 Submitted Original manuscript
13 Feb 2017 Author responded Author comments - Inge Ubink
Resubmission - Version 2
13 Feb 2017 Submitted Manuscript version 2
5 Apr 2017 Editorially accepted
19 Apr 2017 Article published 10.1186/s12885-017-3264-y

You can find further information about peer review here.

Back to article page